Vasovagal Syncope Clinical Trial
Official title:
Relation Between Vasovagal Tendency and Smoking Among University Students
Almost everyone is aware these days is aware about the risk of smoking. Still many people start this habit specially in early life and during college year. We aim to investigate in this study if there is a drive to smoke in people with vasovagal tendency to improve their symptoms, even if not aware of this. Vasovoagal symptoms are common and include dizziness, smoking, sweating, abdominal pain, fatigue and syncope. Some studies have shown correlation between smoking and a positive tilt table test which is indicative of vasovagal tendency. By collecting the information regarding smoking habit and vasovagal symptoms analysis can be done to see if there is correlation between these two factors
Methods
A questionnaire will be conducted among university students to investigate the tendency
toward vasovagal symptoms and also smoking habits. Statistical correlation will be
subsequently conducted to see if there is correlation between those two problems (vasovagal
symptoms and smoking)
Study criteria inclusion
Benefit to the patient:
There is no direct benefit for participation in the study. The information obtained may help
in the future to find factors that increase smoking and being aware of these factors may help
in controlling the habit of smoking.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05621460 -
The Effect of Water Carbonation on Orthostatic Tolerance
|
N/A | |
| Active, not recruiting |
NCT02123056 -
Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects
|
Phase 4 | |
| Completed |
NCT02140567 -
Syncope Prediction Study
|
||
| Active, not recruiting |
NCT01456481 -
Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV
|
Phase 4 | |
| Completed |
NCT00061009 -
Hypnosis in Autonomic Function
|
N/A | |
| Recruiting |
NCT06331819 -
Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
|
||
| Recruiting |
NCT05159687 -
Study of Atomoxetine in the Prevention of Vasovagal Syncope
|
Phase 3 | |
| Completed |
NCT02500732 -
Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
|
Phase 2 | |
| Recruiting |
NCT02018497 -
Essential Hypotension and Allostasis Registry
|
||
| Recruiting |
NCT03446326 -
Assessment of Stroke Volume and Cardiac Output in Response to Varying Heart Rates
|
N/A | |
| Active, not recruiting |
NCT01791816 -
Mechanisms of Vasovagal Syncope
|
Early Phase 1 | |
| Completed |
NCT00292825 -
Effect of Closed Loop Pacemaker Treatment on Recurrent Vasovagal Syncope
|
N/A | |
| Completed |
NCT02636712 -
Observation of ImageReady™ MR Conditional Pacing System in China
|
||
| Completed |
NCT02009982 -
Cardioneuroablation for Neurocardiogenic Syncope
|
N/A | |
| Not yet recruiting |
NCT06166277 -
Cardioneuroablation for Recurrent Vasovagal Syncope and Bradyarrhythmias: The CNA-FWRD Registry
|